• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIH funds new studies on the impact of genomic information

NIH funds new studies on the impact of genomic information

May 17, 2016
CenterWatch Staff

Four new grants from the National Institutes of Health will support research on the ethical, legal and social questions raised by advances in genomics research and the increasing availability of genomic information. The awards will fund researchers at interdisciplinary centers through the National Human Genome Research Institute’s (NHGRI) Centers of Excellence in Ethical, Legal and Social Implications Research (CEER) program.

The projects will examine the use of genomic information in the prevention and treatment of infectious diseases; genomic information privacy; communication about prenatal and newborn genomic testing results; and the impact of genomics in American Indian and Alaskan Native communities.

“Many ethical and social problems are not solved by experts in a single discipline alone,” said Joy Boyer, senior program analyst in NHGRI’s Ethical, Legal and Social Implications Research Program. “The CEER program brings together experts from often disparate fields who speak different languages and forms centers where they can study issues across disciplines. These grants are diverse and forward-looking, while also relevant to public health and medicine today.”

The CEER program, established in 2004, is designed to bring together experts in wide-ranging fields—bioethics, law, behavioral and social sciences, epidemiology, public health, public policy, genomics and clinical research—to study the potential societal implications of genomic information and research. CEER projects also help inform public policy and research guidelines, in addition to educating the next generation of researchers.

Each center is built so researchers can look to the future within specific focus areas. “They enable researchers to anticipate new questions and issues that will arise in their particular field of study, and understand how to address them,” said Lawrence Brody, Ph.D., director of the NHGRI Division of Genomics and Society. “The centers examine the human side of research advances, and tackle subjects at the interface of ever-changing technology and medicine.” 

The grants, totaling approximately $15 million over four years (pending available funds), will support the following research projects:

  • Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease: Gail Geller, Sc.D., Jeffrey Kahn, Ph.D., and colleagues at the Johns Hopkins Berman Institute of Bioethics and Johns Hopkins University in Baltimore will use $4,155,172 over four years to examine the ethical implications of using genomic information to help manage the prevention, control and treatment of infectious diseases. The researchers will develop and conduct three pilot projects that study how genomic information affects infectious disease research, public health policy and clinical practice. The work builds on previous NHGRI-supported research.
  • Genetic Privacy and Identity in Community Settings: Researchers at Vanderbilt University School of Medicine in Nashville, Tennessee, will study privacy risks associated with genomic information. Ellen Wright Clayton, M.D., J.D., and Bradley Malin, Ph.D., will use $4,012,641 over four years to examine factors that influence how people perceive such risks. The researchers will examine the effectiveness of legal and policy efforts to reduce privacy risks, and study the likelihood that lapses in protecting genomic information allow people to be identified. They will develop policies to prevent the loss of privacy that could lead to the use of personal genomic information for unintended purposes, such as to discriminate in decisions about employment and insurance.
  • Utah Center of Excellence in Ethical, Legal and Social Implications Research: Jeffrey Botkin, M.D., M.P.H., and his colleagues at the University of Utah in Salt Lake City are expanding on research on prenatal testing already supported by NHGRI. A grant for $3,881,732 over four years will enable the researchers to study how family members communicate about prenatal and newborn screening, including how test results and risks are communicated, decision-making and couples communication.
  • Center on American Indian and Alaska Native Genomic Research: At the University of Oklahoma in Norman, researchers Paul Spicer, Ph.D., Amanda Cobb-Greetham, Ph.D., Cecil Lewis, Ph.D., and their colleagues will examine how the use of genomic information in medical care could potentially impact American Indian and Alaska Native communities and health care systems. A grant for $3,611,308 over four years will allow the university to partner with the Chickasaw and Lakota Sioux tribes and communities and the Southcentral Foundation in Anchorage, Alaska, to study awareness, knowledge and attitudes about genomics in these communities. The collaboration will help create culturally appropriate research and education programs, as well as tools to develop similar programs in other communities.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing